Artal Group’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-702,291
| Closed | -$11.6M | – | 121 |
|
|
2023
Q2 | $11.6M | Hold |
702,291
| – | – | 0.36% | 42 |
|
|
2023
Q1 | $6.26M | Sell |
702,291
-1,450,000
| -67% | -$12.9M | 0.37% | 56 |
|
|
2022
Q4 | $4.89M | Hold |
2,152,291
| – | – | 0.27% | 61 |
|
|
2022
Q3 | $2.32M | Hold |
2,152,291
| – | – | 0.1% | 82 |
|
|
2022
Q2 | $5.7M | Hold |
2,152,291
| – | – | 0.3% | 50 |
|
|
2022
Q1 | $8.87M | Hold |
2,152,291
| – | – | 0.37% | 52 |
|
|
2021
Q4 | $19.4M | Buy |
2,152,291
+1,302,291
| +153% | +$11.8M | 0.53% | 44 |
|
|
2021
Q3 | $11.5M | Hold |
850,000
| – | – | 0.26% | 67 |
|
|
2021
Q2 | $16.7M | Buy |
+850,000
| New | +$16.7M | 0.34% | 58 |
|